Press release
Pegfilgrastim Biosimilars Market Size, Share, Trends, Growth, Report and Forecast 2024-2032
The report also provides a detailed insight of the market on the basis of patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, and partnership and collaborations analysis.
Pegfilgrastim Biosimilars Market Share, Size, Price, Growth, Trends, Industry Report, Key Player, Major Segments and Forecast
The key highlights of the report include:
Market Overview (2018-2032)
Forecast CAGR (2024-2032): 7%
Growing demand for cost-effective alternatives to biologic drugs is expected to drive the growth of the global pegfilgrastim biosimilars market. The increasing prevalence of cancer and the need for supportive care treatments like neutropenia management offer lucrative growth opportunities to the market. However, challenges in manufacturing processes and regulatory complexities might pose challenges for the pegfilgrastim biosimilars market.
Get a Free Sample Report with a Table of Contents@ https://www.expertmarketresearch.com/reports/pegfilgrastim-biosimilars-market/requestsample
The patent expiration of Neulasta®, a pegfilgrastim drug produced by Amgen, has led to the development of various biosimilars, opening new growth opportunities for the market. These developments, coupled with the growing demand for affordable treatments and strengthening healthcare infrastructure, are likely to contribute to the global pegfilgrastim biosimilars market growth.
Pegfilgrastim Biosimilars Industry Definition and Major Segments
Pegfilgrastim is a PEGylated form of recombinant human granulocyte colony-stimulating factor (G-CSF) analog filgrastim. It is used to stimulate the production of white blood cells, specifically neutrophils, to reduce the risk of infection in patients undergoing chemotherapy. Pegfilgrastim biosimilars are highly similar versions of the original pegfilgrastim drugs, with no clinically meaningful differences in terms of safety and efficacy.
Read Full Report with Table of Contents@ https://www.expertmarketresearch.com/reports/pegfilgrastim-biosimilars-market
Based on indication type, the market is segmented into:
Neutropenia
Hematopoietic Subsyndrome
Others
Based on product type, the market is segmented into:
MK-6302
Peg G-CSF
PEG Neutrogena
Grasustek
LA-EP2006
R-TPR-029
Filgrastim
PEG-GCSF
Others
Based on application, the market is classified into:
Oncology
Chronic and Autoimmune Diseases
Others
Based on distribution channel, the market is bifurcated into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on region, the market is segregated into:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Pegfilgrastim Biosimilars Market Trends
The key trends in the global pegfilgrastim biosimilars market include the growing development and research by the pharmaceutical sector, aimed towards the development of affordable biosimilar drugs. Increased clinical trials for pegfilgrastim biosimilars are projected to drive market growth. Additionally, strategic collaborations between pharmaceutical companies to enhance their biosimilar portfolio are anticipated to impact the growth of the market positively.
The rising prevalence of cancer and the increasing demand for cost-effective treatment options are major factors driving the pegfilgrastim biosimilars market. In addition, favorable government policies and initiatives to promote the use of biosimilars are expected to boost the growth of the market.
Key Market Players
The major players in the global pegfilgrastim biosimilars market report are Merck & Co., Inc., Biocon Limited, Sandoz International GmbH, Intas Pharmaceuticals Ltd., Mylan N.V., Fresenius Kabi AG, Apotex Inc., and Pfizer Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.
The report studies the latest updates in the market, along with their impact across the market. It also analyzes the market demand, together with its price and demand indicators. The report also tracks the market based on SWOT and Porter's Five Forces Models.
Related Report:
Telmisartan Market
https://www.expertmarketresearch.com/reports/telmisartan-market
Cholera Vaccines Market
https://www.expertmarketresearch.com/reports/cholera-vaccines-market
Congenital Hyperinsulinism Market
https://www.expertmarketresearch.com/reports/congenital-hyperinsulinism-market
Laser Hair Removal Market
https://www.expertmarketresearch.com/reports/laser-hair-removal-market
picture archiving and communication system PACS market
https://www.expertmarketresearch.com/reports/picture-archiving-and-communication-system-pacs-market
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pegfilgrastim Biosimilars Market Size, Share, Trends, Growth, Report and Forecast 2024-2032 here
News-ID: 3264917 • Views: …
More Releases from Expert Market Research
Online Music Education Market Size, Growth & Trends (2026-2035)
The online music education market has been rapidly evolving, driven by the increasing popularity of digital platforms and the growing demand for music learning from individuals across different age groups. The market was valued at USD 4.27 Billion in 2025 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 13.20% during the forecast period of 2026-2035, reaching a staggering valuation of USD 14.75 Billion by 2035.…
Global Doors Market Trends (2026-2035): Growth, Drivers, and Future Outlook
The global doors market, valued at approximately USD 164.72 billion in 2025, is set to experience significant growth in the coming years. With a projected CAGR of 5.10% from 2026 to 2035, the market is expected to reach USD 270.88 billion by 2035. The increasing demand for energy-efficient solutions, growing construction activities, and rising investments in residential and commercial infrastructure are major factors fueling this growth. Let's explore the key…
India Vaccine Market Forecast to Hit INR 300.32B by 2035
What is driving the growth of the India vaccine market, and what are the key trends shaping its future?
The India vaccine market is experiencing significant growth due to the country's large population, high prevalence of infectious diseases, and increasing focus on local vaccine production and immunization programs. Valued at INR 129.21 Billion in 2025, the market is projected to grow at a CAGR of 8.80% during 2026-2035, reaching INR 300.32…
Cell and Gene Therapy Market Projected to Grow to USD 172B by 2035
What is driving the growth of the global cell and gene therapy market, and how is it expected to evolve by 2035?
The global cell and gene therapy market is witnessing rapid expansion due to increasing clinical trials, robust regulatory support, and breakthroughs in biotechnology. Valued at USD 21.43 Billion in 2025, the market is expected to grow at a CAGR of 23.17% from 2026 to 2035, reaching USD 172.22 Billion…
More Releases for Peg
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
